First Wave BioPharma (FWBI) Financials

$2.07

up-down-arrow $-- (--%)

As on 14-Jun-2024 09:30EDT

Market cap

info icon

$6 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.9

Div. Yield

info icon

0 %

Income Statement ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Operating Revenue
0.14
--
--
--
--
--
Cost of Revenue
0.07
0.03
0.11
0.54
0.57
0.98
Gross Profit
0.07
-0.03
-0.11
-0.54
-0.57
-0.98
Operating Expenses
20.91
15.74
12.68
56.70
26.43
14.74
Operating Profit (EBIT)
-20.93
-15.77
-12.68
-56.70
-26.43
-14.74
Other Income
--
--
--
--
--
--
Profit before Tax
-21.02
-15.79
-14.63
-58.54
-32.67
-15.18
Provision for Tax
-14.86
0.00
1.95
-0.52
6.05
0.43
Profit after Tax (Net Income)
-6.16
-15.79
-16.58
-58.54
-38.72
-15.61
Minority Interest
--
--
--
--
--
--
Consolidated Profit
--
--
-14.97
-84.52
-41.73
-15.18

Liabilities ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Shareholder's Funds
77.86
3.60
2.74
-7.82
-2.64
4.62
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
7.10
0.15
0.21
7.31
0.02
3.82
Current Liabilities
6.17
3.13
2.48
12.30
15.55
4.29
Total Liabilities
97.31
6.88
5.44
11.79
12.92
8.90

Assets ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Non-Current Assets
83.64
1.93
2.03
2.37
5.05
5.49
Current Assets
7.49
4.96
3.41
9.42
7.87
3.41
Total Assets
97.31
6.88
5.44
11.79
12.92
8.90
Total Debt*
6.98
0.83
0.88
1.03
0.63
1.60
Net Current Assets
1.32
1.82
0.93
-2.88
-7.68
-0.88

Cashflow ($ Mln)

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Cash From Operating Activities
--
-12.38
-22.34
-32.29
-11.22
-14.03
Cash Flow from Investing Activities
--
--
--
-10.32
0.09
-0.02
Cash from Financing Activities
--
15.23
15.74
44.76
17.05
13.14
Net Cash Inflow / Outflow
--
--
--
--
--
--

Financials Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Adjusted EPS ($) info
--
--
--
--
--
--
Cash EPS ($) info
--
--
--
--
--
--
Adjusted Book Value ($) info
--
--
--
--
--
--
Dividend per Share ($) info
--
--
--
--
--
--
Cash Flow per Share ($) info
--
--
--
--
--
--
Free Cash Flow per Share ($) info
--
--
--
--
--
--

Profitability Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
ROCE (%) info
--
--
-392.15
1,047.68
1,329.96
-1,839.58
ROE (%) info
--
-15.18
-497.87
652.88
1,119.03
-3,918.29
ROA (%) info
--
-11.68
-256.35
-192.47
-473.73
-354.83
EBIT Margin (%) info
--
-15,087.22
--
--
--
--
Net Margin (%) info
--
-4,436.70
--
--
--
--
Cash Profit Margin (%) info
--
-0.13
--
--
--
--

Growth Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Revenue Growth (%) info
--
--
--
--
--
--
EBIT Growth (%) info
--
-184.52
-24.39
77.64
-114.53
-79.28
Net Profit Growth (%) info
--
42.99
4.74
71.67
-51.17
-148.04
EPS Growth (%) info
--
--
--
--
--
--
Book Value Growth (%) info
--
--
--
--
--
--

Valuation Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Price / Earnings info
--
--
--
--
--
--
Price / Book Value info
--
1.87
--
--
--
--
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
--
-0.24
0.18
0.04
0.12
0.21
Close Price ($) info
--
4.38
4.20
122.58
6,068.81
40,741.26
High Price ($) info
--
110.00
179.20
7,033.43
110,458.74
81,406.99
Low Price ($) info
--
2.77
2.77
60.24
5,334.13
15,574.83
Market Cap ($ Cr) info
--
5.99
--
--
--
--

Solvency Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Debt to Equity info
--
0.08
0.23
0.32
-0.13
-0.24
Short term debt to equity ratio info
0.40
0.01
0.19
0.24
-0.09
-0.23
Current Ratio info
--
1.21
1.58
1.37
0.77
0.51
Quick Ratio info
--
1.21
--
--
--
--
Interest Coverage info
--
-262.77
-702.08
-798.42
-0.01
-4.53

Operating Efficiency Ratios

TTM Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14
Debtors to sales (%) info
--
--
--
--
--
--
Asset Turnover info
--
0.00
--
--
--
--
Receivable days info
--
--
--
--
--
--
Inventory Days info
--
--
--
--
--
--
Payable days info
--
--
7,949.79
5,849.73
1,441.05
1,207.23
Cash Conversion Cycle info
--
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...